Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
Details for Australian Patent Application No. 2002256133 (hide)
International Classifications
Event Publications
10 April 2003 Application Open to Public Inspection
Published as AU-B-2002256133
31 May 2007 Application Accepted
Published as AU-B-2002256133
27 September 2007 Standard Patent Sealed
3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002256134-CP27 PEPTIDES AND THEIR USE IN MODULATING CELL GROWTH AND APOPTOSIS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser